Cooper Companies Medical Device Company Intelligence Report

Product Code ESP00123
Publication Date July 2011
Publisher Espicom
Product Type Report
Pages 38
ISBN Number not applicable

Cooper Companies Medical Device Company Intelligence Report

The Cooper Companies manufactures and markets speciality healthcare products through its CooperVision and CooperSurgical divisions.

  • CooperVision (CVI), headquartered in Pleasanton, California, US, manufactures and markets a broad range of contact lenses and, following its acquisition of Ocular Sciences in 2005, became one of the most successful players in this market. CVI's primary offices are in the US and the UK and its manufacturing facilities are located in the US, the UK and Puerto Rico. Its principal markets are the US, Europe and the Asia-Pacific region.
  • CooperSurgical (CSI), based on Trumbull, Connecticut, US, manufactures and markets medical devices, diagnostic products and surgical instruments and accessories for women's healthcare, which are primarily used by gynaecologists and obstetricians. The company has mainly developed through small acquisitions, purchasing over 30 businesses over the last 20 years. The most recent acquisition was in April 2011, when CSI acquired Apple Medical, a developer of obstetric and gynaecology products. CSI's primary objective is to service the obstetricians and gynaecologists in the US, since the company believes this is a more US-centric profession. However, the company does have a presence in Europe.

CVI's three largest competitors are Johnson & Johnson's Vistakon division, CIBA Vision (owned by Novartis) and Bausch & Lomb. Together with CVI, these companies represent almost 95% of the global soft contact lens market.

CSI competes primarily with smaller technology-driven companies that generally offer only one or two product lines. However, the company is now expanding into the significantly larger hospital and out-patient surgical procedure market, which is dominated by larger competitors such as Johnson & Johnson's Ethicon Endo-Surgery and Ethicon Women's Health and Urology companies, Boston Scientific, Gyrus ACMI (an Olympus company) and Covidien.

For the financial year ended 31st October 2010 (fiscal 2010), The Cooper Companies reported net income of US$112.8 million on net sales of US$1,158.5 million. This represented increases of 12% and 7%, respectively, when compared with fiscal 2009. CVI generated 84% of The Cooper Companies' revenue, while CSI accounted for the remaining 16% of net sales.

As of June 2011, The Cooper Companies had a total of approximately 7,100 employees.

  • This company report provides
  • Overview
    • Key contact information
    • Introduction to the company and its current activities
    • Summary of its financial performance
    • Who are the company's major competitors?
    • Key recent events in an ""at a glance"" format
  • Financial Review
    • Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
    • Table providing in-depth five-year financial analysis
    • Employee data, including breakdown by company division and geographic location
  • Strategic Focus
  • Investigates the company's aims and its areas of focus
  • Products
  • Core product areas, key brands, product approvals and launches Research and Development
    • How much has been invested in R&D?
    • Where is the research based?
    • What alliances and agreements does the company have and with whom?
  • Manufacturing and Distribution
    • Identifying the company's manufacturing locations
    • Sales and marketing facilities
  • Agreements
    • With whom has the company reached agreements and what do they involve?
    • Key contracts awarded
  • Mergers, Acquisitions, Minority Investments and Divestments
  • Litigation
  • Key Corporate Events

Contents

  • Overview
  • Financial Review
    • First Half Fiscal Year 2011 Financial Results
    • Cvi
    • Csi
    • Fiscal Year 2010 Financial Results
    • Cvi
    • Csi
    • Five-Year Financial Data
    • Outlook
    • Employees
  • Strategic Focus
  • Products
    • Cvi
    • Csi
  • Research and Development
  • Manufacturing and Distribution
    • Manufacturing
    • Distribution
  • Agreements
    • Ciba Vision
    • Gebauer Medizintechnik
    • Advanced Medical Optics
    • Rohto Pharmaceutical Company
    • Eyefinity
    • Welch Allyn
  • Mergers and Acquisitions
    • Apple Medical
    • Asahikasei Aime Assets
    • American Medical Systems Assets
    • Jlj Medical Devices International
    • Intuitive Surgical's Uterine Positioning System
    • Wallach Surgical Devices
    • Lone Star Medical Products
    • Neosurg Technologies/Inlet Medical
    • Ocular Sciences
    • Opti-Centre
    • Milex Products
    • Argus Biomedical's Alphacor and Alphasphere Products
    • Surx' Radiofrequency Bladder Neck Suspension Technology
    • Avalon Medical
    • Prism Enterprises
    • Sage Biopharma
    • Ackrad Laboratories
    • Orthometrix/Norland Medical Systems' Bone Densitometry Business
    • Biocompatibles Eye Care
    • Medscand Medical
    • Cl-Tinters Oy
    • Medamicus' Lumax Fiber Optic Cystometry System
    • Medasonics
    • Leisegang Medical's Women's Healthcare Products
    • Bei Medical Systems' Women's Healthcare Products
    • Aspect Vision Care Ltd
    • Marlow Surgical Technologies
    • Unimar
    • Rumi Uterine Manipulator
  • Minority Investments
    • Quidel
  • Divestitures
    • Coopervision Surgical
    • Quidel
    • Hospital Group of America
  • Litigation
    • Rembrandt Vision Technologies
    • Internal Revenue Service
    • Securities Litigation
  • Key Corporate Events
  • List of Tables
    • Summary Operating Resultsiii
    • Recent Key Events
    • The Cooper Companies - First Half Fiscal 2011 Financial Results
    • The Cooper Companies - First Half Fiscal 2011 Net Sales by Geographic Region
    • Cvi - Selected First Half Fiscal 2011 Financial Results
    • Cvi - First Half Fiscal 2011 Revenues by Key Product
    • Cvi - First Half Fiscal 2011 Sales by Geographic Area
    • Csi - Selected First Half Fiscal 2011 Financial Results
    • The Cooper Companies - Annual Financial Results, Fiscal Years 2006-2010
    • The Cooper Companies - Annual Net Sales by Geographic Region, Fiscal Years 2006-2010
    • Cvi - Selected Annual Financial Results, Fiscal Years 2008-2010
    • Cvi - Annual Revenues by Key Product, Fiscal Years 2008-2010
    • Cvi - Annual Revenues by Geographic Region, Fiscal Years 2008-2010
    • Csi - Selected Annual Financial Results, Fiscal Years 2008-2010
    • The Cooper Companies - Five-Year Financial Summary, Fiscal Years 2006-2010
    • Soft Contact Lens Market by Region and by Competitor, Q1 2011
    • Global Soft Lens Market - Modality Breakdown by Region, Q1 2011
    • Global Soft Contact Lens Market - Estimated Five-Year Sales Trend by Product, Calendar Year 2010-2015
    • Global Soft Contact Lens Market - Estimated Five-Year Sales Trend by Region, Calendar Year 2010-2015
    • Cvi - Key Contact Lens Brands, July 2011
    • Csi Market Shares, Fiscal Year 2009
    • Coopersurgical - Key Products, July 2011
    • Cooper Companies - Annual R&D Expenditure, Fiscal Years 2008-2010
    • Agreements Summary
    • Mergers and Acquisitions Summary
  • List of Charts
    • The Cooper Companies - Annual Net Sales and Operating Income, Fiscal Years 2006-2010
    • The Cooper Companies - Annual Net Sales by Geographic Region, Fiscal Years 2006-2010
    • Cvi - Annual Sales and Operating Income, Fiscal Years 2008-2010
    • Cvi - Annual Net Sales by Geographic Area, Fiscal Years 2008-2010
    • Csi - Annual Net Sales and Operating Income, Fiscal Years 2008-2010
    • Global Soft Contact Lens Market by Competitor, Q1 2011
    • Csi - Office-Based Sales by Product Type, Fiscal 2010
    • Csi - Hospital Sales by Medical Procedure/Segment, Fiscal 2010
    • Csi - Fertility Clinic Sales by Product Type, Fiscal 2010